HK Stock Market Move | During the day, the stock price rose by over 5%. Intelligent driving is expected to enter a period of rapid development. The company is a simulation testing platform for intelligent connected vehicles.
Saimu Technology (02571) rose more than 5% during the trading session, and as of the time of reporting, it was up 4% to HKD 13.52, with a turnover of 3.0649 million Hong Kong dollars.
(02571) rose more than 5% during trading hours, and at the time of publication, it rose by 4% to HKD 13.52, with a turnover of HKD 3.0649 million.
It is reported that this is a Chinese technology company specializing in intelligent connected vehicle (ICV) simulation testing technology, mainly engaged in the design and development of ICV simulation testing products and providing related testing, verification, and evaluation solutions. ICV refers to vehicles equipped with advanced onboard sensors, controllers, brakes, and other devices, integrating advanced communication and network technology.
CMSC believes that intelligence is gradually becoming a key factor in the competition of the automotive industry, similar to the rapid development of smartphones in 2010. We believe that high-level intelligent driving is expected to enter a period of rapid development by 2025. With the maturity of software and hardware algorithms, the reduction of hardware costs, an increase in consumer awareness, and increased competition among car companies, it is expected that high-level intelligent driving will quickly popularize in 100,000 to 200,000 vehicles in the domestic market in the next two years.
Related Articles

Historic moment! The first successful implementation of BNCT treatment in Hainan CH Biotech Co., Ltd. (08037) is revalued and industry breakthroughs.

Annual Report Revelation of CHINA HONGQIAO (01378): Firm Growth as the Foundation, Strengthening Dividend Attributes Further

GMTEight List of A-share restricted sales and lifting restrictions | March 23rd
Historic moment! The first successful implementation of BNCT treatment in Hainan CH Biotech Co., Ltd. (08037) is revalued and industry breakthroughs.

Annual Report Revelation of CHINA HONGQIAO (01378): Firm Growth as the Foundation, Strengthening Dividend Attributes Further

GMTEight List of A-share restricted sales and lifting restrictions | March 23rd

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


